This research demonstrates improved drug delivery in the vagina using PLGA microparticles, suggesting better management of health concerns.
This vaginal drug delivery system offers potential applications for managing VVC, along with other health concerns in women.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: